Loading…
Getting the latest data.
Cards for this view
| # | Trend | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XLK | State Street Technology Select Sector SPDR ETFReadDesk | 0.08% | 0.51% | −3.2% | +14.9% | +15.6% | +24.3% | +15.3% | −19.6% | $116.8B | |
| 2 | ABBC | Virtus Biotech Clinical Trials ETFReadDesk | 0.65% | 1.60% | −4.0% | +5.9% | +32.1% | +34.0% | −2.3% | −30.2% | $32M | |
| 3 | BIDNA | iShares Genomics Immunology and Healthcare ETFReadDesk | 0.47% | 0.72% | −2.1% | +50.5% | +53.5% | +30.5% | −3.6% | −11.1% | $332M |
| # | Trend | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | XLK | State Street Technology Select Sector SPDR ETFReadDesk | 0.08% | 0.51% | −3.2% | +14.9% | +15.6% | +24.3% | +15.3% | −19.6% | $116.8B | |
| 2 | ABBC | Virtus Biotech Clinical Trials ETFReadDesk | 0.65% | 1.60% | −4.0% | +5.9% | +32.1% | +34.0% | −2.3% | −30.2% | $32M | |
| 3 | BIDNA | iShares Genomics Immunology and Healthcare ETFReadDesk | 0.47% | 0.72% | −2.1% | +50.5% | +53.5% | +30.5% | −3.6% | −11.1% | $332M |